Global Vascular Injury Treatment Market Restraints
However, high cost associated with the vascular disease treatment is one of the major factors that is expected to hamper growth of the global vascular injury treatment market. For instance, for peripheral artery disease (PAD) related non-coronary procedures, average cost accounts for US$ 729. In addition, for antihypertensive medication, average cost is US$ 313, while for lipid-lowering therapy, average cost accounts for US$ 207. Moreover, according to the American Heart Association (AHA), in 2035, in U.S, total cost for the treatment of cardiovascular is expected to reach US$ 1.1 trillion. Therefore, high cost for the treatment of vascular disease is expected to hamper growth of the global vascular injury treatment market.
Vascular Injury Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients